Drug Use in Renal Insufficiency
136 - 150 of
202 Results
Sort Results:
Article:
Experts will debate whether gliptins (Onglyza, etc) increase cardiovascular risk in patients with type 2 diabetes
November 2013
Article:
stronger warnings about peripheral neuropathy with oral or IV quinolone antibiotics
October 2013
Article:
more emphasis on patients with A fib NOT stopping Pradaxa (dabigatran), Xarelto (rivaroxaban), or Eliquis (apixaban)
July 2013
Article:
Canadian guidelines will affect the way you manage diabetes patients and address the growing diabetes epidemic
June 2013